Researcher
Current•Designed, formulated, and developed drug product candidates for new therapeutics against CMV, Dengue, CoV-2, and HIV•Executed plasmid and LNP purification processes through the utilization of Fast Protein Liquid Chromatography (FPLC) and Tangential Flow Filtration (TFF,) ensuring high-quality products and efficient downstream processing•Conducted R&D experiments using analytical chemistry (Patfix) to generate data for determining optimal methods for nucleic acid and LNP yield and purification, resulting in improved processes in GMP product production for enhanced efficiency and quality•Spearheaded initiatives in project planning to meet restrictive deadlines on the HIV GMP therapeutic•Managed and executed the transition from small-scale to large-scale plasmid production with bioreactors and a focus on optimizing efficiency and yield while ensuring adherence to GMP standards•Implemented and developed comprehensive SOPs for the creation of a new preclinical GMP facility, ensuring quality control (QC) and regulatory compliance (QMS), streamlined operations, and adherence to aseptic techniques